Urine cytopathology: Challenges, pitfalls, and mimics

Diagnostic Cytopathology

Volumn 40, Issue 11, 2012, Pages 1019-1034

  Thiryayi, S A ^a   Rana, D N ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

challenges; mimics; pitfalls; urine cytopathology

Indexed keywords

ADENOCARCINOMA; ADENOMA; CANCER CLASSIFICATION; CYSTITIS; CYTOLOGY; CYTOPATHOLOGY; DIAGNOSTIC ERROR; ENDOMETRIOSIS; GLANDULAR CYSTITIS; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE CELL; NEPHROGENIC ADENOMA; PRIORITY JOURNAL; REVIEW; TRANSITIONAL CELL CARCINOMA; URINARY TRACT BIOPSY; URINE CYTOPATHOLOGY; UROGENITAL TRACT TUMOR;

ADENOCARCINOMA; BK VIRUS; CELL NUCLEUS SIZE; HUMANS; NEOPLASM GRADING; NUCLEAR ENVELOPE; POLYOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY TRACT; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84867866175     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21769     Document Type: Review

References (98)

1. Bastacky S, Ibrahim S, Wilczynski SP, Murphy WM,. The accuracy of urinary cytology in daily practice. Cancer Cytopathol 1999; 87: 118-128.
2. Caraway NP, Katz RL,. A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis. Cancer Cytopathol 2010; 118: 175-183.
3. DeMay R,. The art and science of cytopathology. Vol 1. Chicago: ASCP Press; 1996. p 385-426.
4. Raab SS,. Urine cytology. In:, Gray W, Kocjan G, editors. Diagnostic cytopathology, 3rd ed. Edinburgh: Churchill Livingstone; 2010. p 381-408.
5. Koss LG, Melamed MR, editors. Koss' diagnostic cytology and its histopathologic bases. Vol. 1, 5th ed. Philadelphia: Lippincott Williams and Wilkins. 2006, p 738-776.
6. Raab SS, Lenel JC, Cohen MB,. Low-grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by regression analysis. Cancer 1994; 74: 1621-1626.
7. Wright RG, Halford JA,. Evaluation of thin-layer methods in urine cytology. Cytopathology 2001; 12: 306-313.
8. Nassar H, Ali-Fehmi R, Madan S,. Use of ThinPrep monolayer technique and cytospin preparation in urine cytology: A comparative analysis. Diagn Cytopathol 2003; 28: 115-118.
9. Elsheikh TM, Kirkpatrick JL, Wu HH,. Comparison of ThinPrep and cytospin preparations in the evaluation of exfoliative cytology specimens. Cancer Cytopathol 2006; 108: 144-149.
10. Deshpande V, McKee GT,. Analysis of atypical urine cytology in a tertiary care center. Cancer Cytopathol 2005; 105: 468-475.
11. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. World health organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004. p 89-157.
12. Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998; 22: 1435-1448.
13. Grignon DJ,. The current classification of urothelial neoplasms. Mod Pathol 2009; 22: S60-S69.
14. Kapur U, Venkataraman G, Wojcik EM,. Diagnostic significance of 'atypia' in instrumented versus voided urine specimens. Cancer Cytopathol 2008; 114: 270-274.
15. Layfield LJ, Elsheikh TM, Fili A, Nayar R, Shidham V,. Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting: The Papanicolaou Society Cytopathology Practice Guidelines Task Force. Diagn Cytopathol 2004; 30: 24-30.
16. Renshaw AA,. Subclassifying atypical urinary cytology specimens. Cancer Cytopathol 2000; 90: 222-229.
17. Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG,. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer 2000; 88: 1663-1670.
18. Murphy WM, Soloway MS, Jukkola AF, Crabtree WN, Ford KS,. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984; 53: 1555-1565.
19. Murphy WM,. Current status of urinary cytology in the evaluation of bladder neoplasms. Hum Pathol 1990; 21: 886-896.
20. Curry JL, Wojcik EM,. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Cancer Cytopathol 2002; 96: 140-145.
21. Arora SK, Dey P, Saikia UN,. Micronucleus in atypical urothelial cells. Diagn Cytopathol 2010; 38: 811-813.
22. Whisnant RE, Bastacky SI, Ohori NP,. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification. Diagn Cytopathol 2003; 28: 186-190.
23. Xin W, Raab SS, Michael CW,. Low-grade urothelial carcinoma: Reappraisal of the cytologic criteria on ThinPrep Diagn Cytopathol 2003; 29: 125-129.
24. Kannan V, Gupta D,. Calculus artifact. A challenge in urinary cytology. Acta Cytol 1999; 43: 794-800.
25. McVey RJ, Persad RV, Brown SCW, Robinson E, Payne SR,. How long is urinary cytology abnormal after flexible cystoscopy? BJU Int 2004; 94: 548-551.
26. Chu YC, Han JY, Han HS, Kim JM, Suh JK,. Cytologic evaluation of low grade transitional cell carcinoma and instrument artifact in bladder washings. Acta Cytol 2002; 46: 341-348.
27. Hughes JH, Raab SS, Cohen MB,. The cytologic diagnosis of low-grade transitional cell carcinoma. Am J Clin Pathol 2000; 114 (Suppl 1): S59-S67.
28. Murata S-I, Kishikawa T, Isojima Y, Tsuchihashi Y, Katoh R,. Unusual cytologic findings in low grade papillary transitional cell carcinoma. Acta Cytol 2004; 48: 492-496.
29. Hattori M, Nishino Y, Kakinuma H, Matsumoto K, Ohbu M, Okayasu I,. Cell cannibalism and nucleus-fragmented cells in voided urine. Useful parameters for cytologic diagnosis of low-grade urothelial carcinoma. Acta Cytol 2007; 51: 547-551.
30. Ohsaki H, Haba R, Matsunaga T, Nakamura M, Kiyomoto H, Hirakawa E,. 'Cannibalism' (cell phagocytosis) does not differentiate reactive renal tubular cells from urothelial carcinoma cells. Cytopathology 2009; 20: 224-230.
31. Goldstein ML, Whitman T, Renshaw AA,. Significance of cell groups in voided urine. Acta Cytol 1998; 42: 290-294.
32. Amin MB,. Histological variants of urothelial carcinoma: Diagnostic, therapeutic and prognostic implications. Mod Pathol 2009; 22: S96-S118.
33. Owens CL, Ali SZ,. Atypical squamous cells in exfoliative urinary cytology: Clinicopathologic correlates. Cytopathology 2005; 33: 394-398.
34. Rosa M,. Clinical significance of dysplastic squamous cells in exfoliative urine cytology. Diagn Cytopathol 2010; 38: 468-469.
35. Shanks JH, Iczkowski KA,. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics. Histopathology 2009; 54: 885-900.
36. Lau SK,. Cytomorphologic features of the plasmacytoid variant of urothelial carcinoma: A case report. Diagn Cytopathol 2009; 37: 359-364.
37. Cardillo M, Reuter VE, Lin O,. Cytologic features of the nested variant of urothelial carcinoma. A study of seven cases. Cancer Cytopathol 2003; 99: 23-27.
38. Shimada K, Nakamura M, Konishi N,. A case of urothelial carcinoma with triple variants featuring nested, plasmacytoid, and lipoid cell morphology. Diagn Cytopathol 2009; 37: 272-276.
39. Young RH,. Non-neoplastic disorders of the urinary bladder. In:, Bostwick DG, Cheng L, editors. Urologic surgical pathology. 2nd ed. Philadelphia: Mosby; 2008. p 215-256.
40. Pantanowitz L, Otis CN,. Cystitis glandularis. Diagn Cytopathol 2008; 36: 181-182.
41. Mazal PR, Schaufler R, Altenhuber-Müller R, et al. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients. N Engl J Med 2002; 347: 653-659.
42. Henke AC, Callaghan EJ, Timmerman TG, Hughes JH,. Nephrogenic adenoma mimicking carcinoma: A potential pitfall in cytodiagnosis. Diagn Cytopathol 2000; 22: 49-51.
43. Herlitz LC, Tong G-X, Hamele-Bena D, Greenebaum E,. Nephrogenic adenoma identified on urine cytology using PAX-2 immunostaining. Diagn Cytopathol 2008; 26: 47-49.
44. Peterson RO, Sesterhenn IA, Davis CJ,. Urologic pathology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008. 656 p.
45. Hao H, Torii Y, Yamamoto T, Hirota S,. Cytologic features of urinary bladder endocervicosis. Acta Cytol 2010; 54: 1061-1063.
46. Bohlmeyer TJ, Shroyer KR,. Endometriosis of the bladder: Cytologic findings and differentiation from transitional cell carcinoma. Acta Cytol 1996; 40: 382-383.
47. Koren J, Mensikova J, Mukensnabl P, Zamecnik M,. Mullerianosis of the urinary bladder: Report of a case with suggested metaplastic origin. Virchows Arch 2006; 449: 268-271.
48. Hao H, Tsujimoto M, Tsubamoto H, Komori S, Hirota S,. Immunohistochemical phenotype of the urinary bladder endocervicosis: Comparison with normal endocervix and well-differentiated mucinous adenocarcinoma of uterine cervix. Pathol Int 2010; 60: 528-532.
49. Julié C, Boyé K, Desgrippes A, et al. Endocervicosis of the urinary bladder. Immunohistochemical comparative study between a new case and normal uterine endocervices. Pathol Res Pract 2002; 198: 115-120.
50. Bardales RH, Pitman MB, Stanley MW, Korourian S, Suhrland MJ,. Urine cytology of primary and secondary urinary bladder adenocarcinoma. Cancer Cytopathol 1998; 84: 335-343.
51. Gopalan A, Sharp DS, Fine SW, et al. Urachal carcinoma. A clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol 2009; 33: 659-668.
52. Grignon DJ, Ro JY, Ayala AG, Johnson De, Ordõñez NG,. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer 1991; 67: 2165-2172.
53. Young RH, Eble JN,. Unusual forms of carcinoma of the urinary bladder. Hum Pathol 1991; 22: 948-965.
54. Bates AW, Baithun SI,. Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: Clinicopathological and histological features of 282 cases. Histopathology 2000; 36: 32-40.
55. Nakanishi K, Tominaga S, Kawai T, Torikata C, Aurues T, Ikeda T,. Mucin histochemistry in primary adenocarcinoma of the urinary bladder (of urachal or vesicular origin) and metastatic adenocarcinoma originating in the colorectum. Pathol Int 2000; 50: 297-303.
56. Bates AW, Baithun SI,. The significance of secondary neoplasms of the urinary and male genital tract. Virchows Arch 2002; 440: 640-647.
57. Morichetti D, Mazzucchelli R, Lopez-Beltran A, et al. Secondary neoplasms of the urinary system and male genital organs. BJU Int 2009; 104: 770-776.
58. Eissa SS, Block N, Khaled HM, Shoman SH, Nassiri M, Nadji M,. Primary enteric-type adenocarcinomas of the urinary bladder are histogenetically analogous to colorectal carcinomas: Immunohistochemical evaluation of 109 cases. J Adv Res 2010; 1: 151-156.
59. Tyler KL, Selvaggi SM,. Morphologic features of prostatic adenocarcinoma on ThinPrep urinary cytology. Diagn Cytopathol 2011; 39: 101-104.
60. Mai KT, Ahmed I, Robertson SJ, Belanger EC, Veinot JP, Islam S,. Immunocytochemical study of urine cytologic preparations from secondary prostatic adenocarcinoma involving the urinary bladder. Diagn Cytopathol 2008; 36: 715-720.
61. Herawi M, Parwani AV, Chan T, Ali SZ, Epstein JI,. Polyoma virus-associated cellular changes in the urine and bladder biopsy sample. A cytohistologic correlation. Am J Surg Pathol 2006; 30: 345-350.
62. De Las Casas LE, Hoerl HD, Bardales RH, et al. Utility of urinary cytology for diagnosing human polyoma virus infection in transplant recipients: A study of 37 cases with electron microscopic analysis. Diagn Cytopathol 2001; 25: 376-381.
63. Drachenberg RC, Drachenberg CB, Papadimitriou JC, et al. Morphological spectrum of polyoma virus disease in renal allografts: Diagnostic accuracy of urine cytology. Am J Transplant 2001; 1: 373-381.
64. Koss LG,. On decoy cells. Acta Cytol 2005; 49: 233-234.
65. Boon ME, van Keep JP, Kok LP,. Polyomavirus infection versus high-grade bladder carcinoma. The importance of cytologic and comparative morphometric studies of plastic-embedded voided urine sediments. Acta Cytol 1998; 33: 887-893.
66. Küpper T, Stoffels U, Pawlita M, Bürrig KF, Pfitzer P,. Morphological changes in urothelial cells replicating human polyomavirus BK. Cytopathology 1993; 4: 361-368.
67. Galed-Placed I, Valbuena-Ruvira L,. Decoy cells and malignant cells coexisting in the urine from a transplant recipient with BK virus nephropathy and bladder adenocarcinoma. Diagn Cyopathol 2010. [Epub ahead of print].
68. Singh HK, Bubendorf L, Mihatsch MJ, Drachenberg CB, Nickeleit V,. Urine cytology findings of polyomavirus infections. In:, Ahsan N, editor. Polyomaviruses and human diseases (Advances in experimental medicine and biology). New York: Springer; 2006. p 201-212.
69. Crabbe JG,. "Comet" or "decoy" cells found in urinary sediment smears. Acta Cytol 1971; 15: 303-305.
70. Cimbaluk D, Pitelka L, Kluskens L, Gattuso P,. Update on human polyomavirus BK nephropathy. Diagn Cytopathol 2009; 37: 773-779.
71. Weinreb DB, Desman GT, Amolat-Apiado MJM, Burstein DE, Godbold JH, Jr, Johnson EM,. Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn Cytopathol 2006; 34: 201-203.
72. Wang HH, Liu KL, Shu SH, Tian YC, Lai PC, Chiang YJ,. BK virus infection in association with posttransplant urothelial carcinoma. Transplant Proc 2009; 41: 165-166.
73. Loghavi S, Bose S,. Polyomavirus infection and urothelial carcinoma. Diagn Cytopathol 2010. [Epub ahead of print].
74. Anagnostopoulou I, Rammou-Kinia R, Likourinas M,. Urine cytology evaluation in cases of uretero-ileal cutaneous diversion. Cytopathology 1995; 6: 268-272.
75. Ajit D, Dighe SB, Desai SB,. Cytology of ileal condut urine in bladder cancer patients: Diagnostic utility and pitfalls. Acta Cytol 2006; 50: 70-73.
76. Bhan R, Pisharodi LR, Gudlaugsson E, Bedrossian C,. Cytological, histological, and clinical correlations in intravesical Bacillus Calmette-Guerin immunotherapy. Ann Diagn Pathol 1998; 2: 55-60.
77. Arora SK, Gupta N, Nijhawan R, Mandal AK,. Epithelioid cell granulomas in urine cytology smears: Same cause, different implications. Diagn Cytopathol 2010; 38: 765-767.
78. Takashi M, Schenck U, Koshikawa T, Nakashima N, Ohshima S,. Cytological changes induced by intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer. Urol Int 2000; 64: 74-81.
79. Martinez-Girõn R,. Intravesical Bacillus Calmette-Guérin effects in voided urine cytology. Diagn Cytopathol 2008; 37: 425-426.
80. Lopez-Beltran A, Luque RJ, Mazzucchelli R, Scarpelli M, Montironi R,. Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. J Clin Pathol 2002; 55: 641-647.
81. Valente PT, Schantz HD,. Iatrogenic artifacts in cytology. Pathol Case Rev 2003; 8: 126-133.
82. Koshikawa T, Leyh H, Schenck U,. Difficulties in evaluating urinary specimens after local mitomycin therapy of bladder cancer. Diagn Cytopathol 1989; 5: 117-121.
83. Fanning CV, Staerkel GA, Sneige N, Thomsen S, Myhre MJ, Von Eschenbach AC,. Spindling artifact or urothelial cells in post-laser treatment urinary cytology. Diagn Cytopathol 1993; 9: 279-281.
84. Perez-Montiel D, Wakely PE, Jr, Hes O, Michal M, Suster S,. High-grade urothelial carcinoma of the renal pelvis: Clinicopathologic study of 108 cases with emphasis on unusual morphologic variants. Mod Pathol 2008; 19: 494-503.
85. Potts SA, Thomas PA, Cohen MB, Raab SS,. Diagnostic accuracy and key cytologic features of high-grade transitional cell carcinoma in the upper urinary tract. Mod Pathol 1997; 10: 657-662.
86. Highman WJ,. Transitional carcinoma of the upper urinary tract: A histological and cytopathological study. J Clin Pathol 1986; 39: 297-305.
87. Nguyen G-K, Smith R,. Repair renal tubular cells: A potential false-positive diagnosis in urine cytology. Diagn Cytopathol 2004; 31: 342-346.
88. Ohsaki H, Haba R, Matsunaga T, Nakamura M, Kiyomoto H, Hirakawa E,. Cytomorphologic and immunocytochemical characteristics of reactive renal tubular cells in renal glomerular disease. Acta Cytol 2008; 52: 297-303.
89. Ohsaki H, Hirakawa E, Kushida Y, et al. Can cytological features differentiate reactive renal tubular cells from low-grade urothelial carcinoma cell? Cytopathology 2010; 21: 326-333.
90. Ohsaki H, Hirakawa E, Nakamura M, Norimatsu Y, Kiyomoto H, Haba R,. Expression of vimentin and high-molecular-weight cytokeratin (clone 34βE12) in differentiating reactive renal tubular cells from low-grade urothelial carcinoma cells in voided urine. Cytopathology 2010. [Epub ahead of print].
91. Kawakami H, Hoshida Y, Hanai J, et al. Voided urine cytology of papillary renal cell carcinoma and renal calculus. Acta Cytol 2001; 45: 771-774.
92. Knoepp SM, Kunju LP, Roh MH,. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology. Diagn Cytopathol 2010. [Epub ahead of print].
93. Tejerina E, González-Peramato P, Jiménez-Heffernan JA, et al. Cytological features of chromophobe renal cell carcinoma, classic type. A report of nine cases. Cytopathology 2009; 20: 44-49.
94. Ohsaki H, Hirakawa E, Kushida Y, Kadota K, Ishikawa M, Haba R,. Cytological features of carcinoma of the collecting ducts of bellini in voided urine cytology. Diagn Cytopathol 2009; 37: 676-679.
95. Nguyen G-K, Schumann GB,. Cytopathology of renal collecting duct carcinoma in urine sediment. Diagn Cytopathol 1997; 16: 446-449.
96. Bernstein J, Evan AP, Gardner KD, Jr,. Epithelial hyperplasia in human polycystic kidney diseases. Its role in pathogenesis and risk of neoplasia. Am J Pathol 1987; 129: 92-101.
97. Têtu B,. Diagnosis of urothelial carcinoma from urine. Mod Pathol 2009; 22: S53-S59.
98. Mowatt G, Zhu S, Kilonzo M, et al. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess 2010; 14: 1-331.